$1.770
+0.117 (+6.63%)At close
TNON News
TNON Events
Tenon Medical Completes Initial Alpha Cases for Quickstep
Tenon Medical announced the completion of the initial alpha cases with its new Quickstep Decorticator. Quickstep is the latest advancement in a line of technology that makes up Tenon's next-generation SI joint fusion systems. The Company is targeting full market release of Quickstep in the first quarter of 2027. The alpha cases follow the recent full market launch of the Company's titanium 3D-printed lateral screw as part of the SImmetry+ SI Joint Fusion System.
Tenon Medical Secures 8 New Patents
Tenon Medical announced that the U.S. Patent and Trademark Office has issued 8 new patents to the Company so far in 2026 fiscal year. With these additions, Tenon holds 38 issued U.S. patents and 9 international patents and has 31 U.S. and foreign patent applications pending. The Company believes that these 8 recently issued patents continue to solidify and strengthen the Company's position as an innovator in the rapidly growing sacro-pelvic fusion market. Encompassing both strategic systems and method claims, the patents provide underlying protection for the Company's Catamaran SI Joint Fusion System, a platform that is intended to redefine the standard of care in sacroiliac joint treatment. Together, these intellectual property additions reflect Tenon's continued commitment to innovation and patient care. The Company offers a modern, integrated SI joint fusion portfolio with applications in SI joint fusion, spinal fusion, and deformity adjuncts, each engineered to help deliver reliable fusion outcomes.
Selling Stockholders Plan to Sell 858,269 Shares of Common Stock
This filing relates to the offer and sale from time to time by the selling stockholders of up to 858,269 shares of common stock. The company is not selling any shares under this prospectus and will not receive any of the proceeds from the sale of shares by the selling stockholders.
Tenon Medical Launches New Titanium 3D-Printed Lateral Screw
Tenon Medical announced the full commercial launch of its new titanium 3D- printed lateral screw as part of the SImmetry+ SI Joint Fusion System following the successful completion of the implant's Alpha launch. The limited Alpha launch, involving existing SImmetry users and new physicians, generated approximately $1.2M in incremental revenue for a period beginning in late Q4 2025 through Q3 2026. The Company plans to support anticipated demand for the SImmetry+ System by expanding its instrument set inventory as needed. Physician feedback from the Alpha launch was positive, with users highlighting the system's new screw design along with the system's ability to decorticate the joint prior to implantation, a step intended to strengthen joint fusion. SImmetry+ is a novel, minimally invasive, lateral and posterior oblique-access SI joint fusion system featuring new 3D-printed titanium implants and proprietary instrumentation. The System is built on established orthopedic principles, including joint decortication, bone graft delivery, and fixation, to achieve fusion of the sacroiliac joint in an efficient manner. In response to input from Alpha users and newly trained surgeons preparing for their first cases, Tenon has expanded the SImmetry+ portfolio with two additional implant sizes, broadening the range of patient anatomies the system can address.
Tenon Medical Inc Trading Halted
Tenon Medical Inc trading halted, volatility trading pause
Related articles
- CPI Report and the Stock Market: How to Read October 2026 Inflation Data Before the Fed DecidesOctober 2026 CPI lands Nov 10 with no year-over-year number and Fed hike odds near 80%. Learn how to read CPI, which stocks react, and how to plan for it.
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.